150 related articles for article (PubMed ID: 19344413)
1. Simultaneous targeting of MCL1 and ABCB1 as a novel strategy to overcome drug resistance in human leukaemia.
Ji M; Li J; Yu H; Ma D; Ye J; Sun X; Ji C
Br J Haematol; 2009 Jun; 145(5):648-56. PubMed ID: 19344413
[TBL] [Abstract][Full Text] [Related]
2. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
[TBL] [Abstract][Full Text] [Related]
3. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
5. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
Mol Pharmacol; 2007 Oct; 72(4):1045-53. PubMed ID: 17636047
[TBL] [Abstract][Full Text] [Related]
7. Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells.
Peng Z; Xiao Z; Wang Y; Liu P; Cai Y; Lu S; Feng W; Han ZC
Cancer Gene Ther; 2004 Nov; 11(11):707-12. PubMed ID: 15375375
[TBL] [Abstract][Full Text] [Related]
8. Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation.
Nakano Y; Bilim V; Yuuki K; Muto A; Kato T; Nagaoka A; Tomita Y
Prostate Cancer Prostatic Dis; 2009; 12(1):34-40. PubMed ID: 18475287
[TBL] [Abstract][Full Text] [Related]
9. Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing.
Zhao Y; Zhang CL; Zeng BF; Wu XS; Gao TT; Oda Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):642-7. PubMed ID: 19818735
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.
Estes DA; Lovato DM; Khawaja HM; Winter SS; Larson RS
Br J Haematol; 2007 Oct; 139(1):20-30. PubMed ID: 17854304
[TBL] [Abstract][Full Text] [Related]
11. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi.
Xiao H; Wu Z; Shen H; Luo AL; Yang YF; Li XB; Zhu DY
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):342-8. PubMed ID: 18834355
[TBL] [Abstract][Full Text] [Related]
12. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cells.
Wang X; Wang C; Qin YW; Yan SK; Gao YR
Leuk Res; 2007 Jul; 31(7):989-94. PubMed ID: 17067671
[TBL] [Abstract][Full Text] [Related]
14. [Reversal of multi-drug resistance in K562/A02 cells by two short hairpin RNAs (shRNA) of mdr1].
Yu HQ; Ji CY; Ma DX; Zang SL
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):456-60. PubMed ID: 17147248
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 gene silencing in pediatric epithelial liver tumors.
Warmann SW; Frank H; Heitmann H; Ruck P; Herberts T; Seitz G; Fuchs J
J Surg Res; 2008 Jan; 144(1):43-8. PubMed ID: 17574594
[TBL] [Abstract][Full Text] [Related]
16. ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells.
Krech T; Scheuerer E; Geffers R; Kreipe H; Lehmann U; Christgen M
Cancer Lett; 2012 Feb; 315(2):153-60. PubMed ID: 22118813
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
18. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.
Wei G; Twomey D; Lamb J; Schlis K; Agarwal J; Stam RW; Opferman JT; Sallan SE; den Boer ML; Pieters R; Golub TR; Armstrong SA
Cancer Cell; 2006 Oct; 10(4):331-42. PubMed ID: 17010674
[TBL] [Abstract][Full Text] [Related]
19. The reversion effect of the RNAi-silencing mdr1 gene on multidrug resistance of the leukemia cell HT9.
Shao SL; Sun YY; Li XY; Zhang WW; Fu B; Yun DZ; Zuo MX
Cell Biol Int; 2008 Aug; 32(8):893-8. PubMed ID: 18499486
[TBL] [Abstract][Full Text] [Related]
20. Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons.
Mori M; Burgess DL; Gefrides LA; Foreman PJ; Opferman JT; Korsmeyer SJ; Cavalheiro EA; Naffah-Mazzacoratti MG; Noebels JL
Cell Death Differ; 2004 Nov; 11(11):1223-33. PubMed ID: 15286683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
